While the treatment of cancer patients can lead to long-term survival, it should be appreciated that bone loss can occur due to:
Estrogen deficiency in women unable to take estrogen because of breast cancer
Testosterone deficiency in men with prostate cancer who may have their hormone secretion reduced by a drug which inhibits testosterone secretion
This can lead to the development of osteoporosis and the complication of fractures over time. This complication can be prevented by early evaluation of bone density at the time treatment begins and by appropriate use of medications which are very successful in preventing bone loss.
Our specialists have decades of experience in diagnosing and treating osteoporosis after cancer therapy in both men and women, and our senior physician is one of the leaders in the field internationally and nationally.